Divay Chandra1, Aman Gupta1, Gregory L Kinney2, Carl R Fuhrman3, Joseph K Leader3, Alejandro A Diaz4, Jessica Bon1, R Graham Barr5, George Washko4, Matthew Budoff6, John Hokanson2, Frank C Sciurba7. 1. Department of Medicine, University of Pittsburgh, Pittsburgh, PA. 2. Department of Epidemiology, University of Colorado, Denver, CO. 3. Department of Radiology, University of Pittsburgh, Pittsburgh, PA. 4. Pulmonary and Critical Care Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. 5. Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY. 6. Department of Medicine, University of California at Los Angeles, Los Angeles, CA. 7. Department of Medicine, University of Pittsburgh, Pittsburgh, PA. Electronic address: sciurbafc@upmc.edu.
Abstract
BACKGROUND: Smokers manifest varied phenotypes of pulmonary impairment. RESEARCH QUESTION: Which pulmonary phenotypes are associated with coronary artery disease (CAD) in smokers? STUDY DESIGN AND METHODS: We analyzed data from the University of Pittsburgh COPD Specialized Center for Clinically Oriented Research (SCCOR) cohort (n = 481) and the Genetic Epidemiology of COPD (COPDGene) cohort (n = 2,580). Participants were current and former smokers with > 10 pack-years of tobacco exposure. Data from the two cohorts were analyzed separately because of methodologic differences. Lung hyperinflation was assessed by plethysmography in the SCCOR cohort and by inspiratory and expiratory CT scan lung volumes in the COPDGene cohort. Subclinical CAD was assessed as the coronary artery calcium score, whereas clinical CAD was defined as a self-reported history of CAD or myocardial infarction (MI). Analyses were performed in all smokers and then repeated in those with airflow obstruction (FEV1 to FVC ratio, < 0.70). RESULTS: Pulmonary phenotypes, including airflow limitation, emphysema, lung hyperinflation, diffusion capacity, and radiographic measures of airway remodeling, showed weak to moderate correlations (r < 0.7) with each other. In multivariate models adjusted for pulmonary phenotypes and CAD risk factors, lung hyperinflation was the only phenotype associated with calcium score, history of clinical CAD, or history of MI (per 0.2 higher expiratory and inspiratory CT scan lung volume; coronary calcium: OR, 1.2; 95% CI, 1.1-1.5; P = .02; clinical CAD: OR, 1.6; 95% CI, 1.1-2.3; P = .01; and MI in COPDGene: OR, 1.7; 95% CI, 1.0-2.8; P = .05). FEV1 and emphysema were associated with increased risk of CAD (P < .05) in models adjusted for CAD risk factors; however, these associations were attenuated on adjusting for lung hyperinflation. Results were the same in those with airflow obstruction and were present in both cohorts. INTERPRETATION: Lung hyperinflation is associated strongly with clinical and subclinical CAD in smokers, including those with airflow obstruction. After lung hyperinflation was accounted for, FEV1 and emphysema no longer were associated with CAD. Subsequent studies should consider measuring lung hyperinflation and examining its mechanistic role in CAD in current and former smokers.
BACKGROUND: Smokers manifest varied phenotypes of pulmonary impairment. RESEARCH QUESTION: Which pulmonary phenotypes are associated with coronary artery disease (CAD) in smokers? STUDY DESIGN AND METHODS: We analyzed data from the University of Pittsburgh COPD Specialized Center for Clinically Oriented Research (SCCOR) cohort (n = 481) and the Genetic Epidemiology of COPD (COPDGene) cohort (n = 2,580). Participants were current and former smokers with > 10 pack-years of tobacco exposure. Data from the two cohorts were analyzed separately because of methodologic differences. Lung hyperinflation was assessed by plethysmography in the SCCOR cohort and by inspiratory and expiratory CT scan lung volumes in the COPDGene cohort. Subclinical CAD was assessed as the coronary artery calcium score, whereas clinical CAD was defined as a self-reported history of CAD or myocardial infarction (MI). Analyses were performed in all smokers and then repeated in those with airflow obstruction (FEV1 to FVC ratio, < 0.70). RESULTS: Pulmonary phenotypes, including airflow limitation, emphysema, lung hyperinflation, diffusion capacity, and radiographic measures of airway remodeling, showed weak to moderate correlations (r < 0.7) with each other. In multivariate models adjusted for pulmonary phenotypes and CAD risk factors, lung hyperinflation was the only phenotype associated with calcium score, history of clinical CAD, or history of MI (per 0.2 higher expiratory and inspiratory CT scan lung volume; coronary calcium: OR, 1.2; 95% CI, 1.1-1.5; P = .02; clinical CAD: OR, 1.6; 95% CI, 1.1-2.3; P = .01; and MI in COPDGene: OR, 1.7; 95% CI, 1.0-2.8; P = .05). FEV1 and emphysema were associated with increased risk of CAD (P < .05) in models adjusted for CAD risk factors; however, these associations were attenuated on adjusting for lung hyperinflation. Results were the same in those with airflow obstruction and were present in both cohorts. INTERPRETATION: Lung hyperinflation is associated strongly with clinical and subclinical CAD in smokers, including those with airflow obstruction. After lung hyperinflation was accounted for, FEV1 and emphysema no longer were associated with CAD. Subsequent studies should consider measuring lung hyperinflation and examining its mechanistic role in CAD in current and former smokers.
Authors: Bin Zheng; Joseph K Leader; Jessica M McMurray; Sang Cheol Park; Carl R Fuhrman; David Gur; Frank C Sciurba Journal: Med Phys Date: 2007-07 Impact factor: 4.071
Authors: Jessica Bon; Carl R Fuhrman; Joel L Weissfeld; Steven R Duncan; Robert A Branch; Chung-Chou H Chang; Yingze Zhang; Joseph K Leader; David Gur; Susan L Greenspan; Frank C Sciurba Journal: Am J Respir Crit Care Med Date: 2010-10-08 Impact factor: 21.405
Authors: Yoon Kyung Kim; Yon Mi Sung; So Hyun Cho; Young Nam Park; Hye-Young Choi Journal: Int J Cardiovasc Imaging Date: 2014-08-02 Impact factor: 2.357
Authors: Tsuneo Yamashiro; Shin Matsuoka; Brian J Bartholmai; Raúl San José Estépar; James C Ross; Alejandro Diaz; Sadayuki Murayama; Edwin K Silverman; Hiroto Hatabu; George R Washko Journal: Acad Radiol Date: 2010-01-12 Impact factor: 3.173
Authors: Surya P Bhatt; Ella A Kazerooni; John D Newell; John E Hokanson; Matthew J Budoff; Chandra A Dass; Carlos H Martinez; Sandeep Bodduluri; Francine L Jacobson; Andrew Yen; Mark T Dransfield; Carl Fuhrman; Hrudaya Nath Journal: Chest Date: 2018-06-08 Impact factor: 9.410
Authors: Surya P Bhatt; Hrudaya P Nath; Young-Il Kim; Rekha Ramachandran; Jubal R Watts; Nina L J Terry; Sushil Sonavane; Swati P Deshmane; Prescott G Woodruff; Elizabeth C Oelsner; Sandeep Bodduluri; MeiLan K Han; Wassim W Labaki; J Michael Wells; Fernando J Martinez; R Graham Barr; Mark T Dransfield Journal: Respir Res Date: 2018-12-18